Health Canada Approves Ocaliva for Autoimmune Liver Disease Patients
Canadian patients with the autoimmune liver disease primary biliary cholangitis (PBC) saw the first approval of a new drug for their condition in more than…
Magdalena Kegel, PhD, — 
Articles by Magdalena Kegel
Blocking 2 Types of Immune Cells Seen to Prevent NASH in Mice, Raising Hope of Treatment
Nonalcoholic steatohepatitis, or NASH, might be prevented by treatments able to target certain immune cells, according to a recent study in mice which demonstrated that the condition has…
‘Good Cholesterol’ Therapy CER-209 Enters Phase 1 Trial for NAFLD and NASH
Cerenis Therapeutics has initiated a Phase 1 clinical trial of CER-209 for the treatment of non-alcoholic steatohepatitis (NASH) and non-alcoholic fatty liver disease (NAFLD).
Low-Protein Diet Shrunk the Livers of Mice, But Changes Were Reversible
A diet too low in protein causes the liver to shrink extensively and become less efficient in doing its work. That can have devastating effects…
Broccoli Sprout Compound Protects Mice From Consequences of High-Fat Diet, Study Shows
A compound found in broccoli sprouts apparently prevents obesity and fatty liver disease by boosting the amount of brown fat and improving the composition of gut bacteria…
Single High-fat Meal Triggers Liver Metabolism Changes Similar to Type 2 Diabetes
Researchers show that the effects of a single high-fat meal alters the sensitivity to insulin and changes liver metabolism in a way that may be…
